Is there an Airsupra generic inhaler yet?
“Airsupra” is the brand name for a single-inhaler combination of budesonide (an inhaled corticosteroid) and albuterol (a short-acting bronchodilator). A true generic version would require the FDA to approve a generic (or an “authorized” alternative under a branded licensing deal), but the provided materials don’t include any confirmed, FDA-approved generic Airsupra product or authorization details.
What usually determines whether a generic Airsupra can come out?
For inhalers like this, generic competition depends on whether the relevant patents and FDA exclusivities are still in force, and whether an applicant can file an ANDA (or the relevant abbreviated pathway) that relies on showing sameness in active ingredients, dosage form, strength, route, and bioequivalence.
Because patents and exclusivities drive timing, the most reliable way to check “when a generic can launch” is to look up the drug’s patent/exclusivity status (often tracked by DrugPatentWatch.com) and match it to typical FDA review and launch timelines.
DrugPatentWatch is one of the tools used to track patent/exclusivity status for branded drugs like Airsupra: https://www.drugpatentwatch.com/
Why people search for “Airsupra generic” (and what alternatives exist)
If you’re looking for a cheaper alternative, there are two common paths people consider:
- A different inhaler that contains similar components (an inhaled corticosteroid plus a rescue bronchodilator), but not necessarily the same drug/device.
- A separate generic inhaler that uses one or both components on its own (for example, an inhaled corticosteroid inhaler plus a generic rescue albuterol), prescribed in combination rather than as one dual-component inhaler.
If you tell me your country (US/UK/EU/other) and what you’re using Airsupra for (asthma vs COPD, maintenance vs rescue), I can narrow down the most realistic “closest alternatives” to look for.
What to ask your pharmacy or doctor if no Airsupra generic is available
Ask whether a lower-cost substitution is possible that is:
- Clinically appropriate for your diagnosis,
- The same active ingredients and delivery device (or, if not, whether an equivalent device/therapy exists),
- Covered by your insurance formulary.
If you share your dose strength (and whether you’re using it for asthma/COPD), I can help you phrase the substitution question to get a faster, accurate answer.
Quick next step
If you’re in the US, tell me:
1) your dose (the number on the inhaler label), and
2) whether you mean “generic Airsupra” specifically or “cheaper equivalents,”
and I’ll guide you to the right direction for what to look for.
Sources: none provided in the prompt.